Literature DB >> 7839430

N-acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia.

K Fukuzawa1, S Emre, O Senyuz, K Acarli, M E Schwartz, C M Miller.   

Abstract

Glutathione is important in cellular defense against oxidative stress. We postulated that administration of N-acetylcysteine (NAC), a glutathione precursor, might help maintain or replenish hepatic glutathione stores, thereby reducing reperfusion injury in liver grafts after warm ischemia. Eighteen pigs were subjected to 2 hr of warm hepatic ischemia and divided into a control group (group A, n = 6), a preischemia treatment group (group B, n = 6: NAC, 150 mg/kg, continuous i.v. infusion 1 hr before ischemia), and a postischemia treatment group (group C, n = 6: NAC, 150 mg/kg continuous i.v., begun 20 min before reperfusion and continued for 1 hr). At initiation of laparotomy, we measured hepatic levels of reduced glutathione (GSH), its oxidized form (GSSG), ATP, aspartate aminotransferase (AST), and lactate dehydrogenase (LDH). Before reperfusion, after 2 hr of warm ischemia, GSH, GSSG, and ATP were measured. One hour after reperfusion, we measured GSH, GSSG, ATP, AST, and LDH. Bile output was recorded every 10 min. Postoperfusion AST and LDH were significantly lower in both treatment groups than in controls. In group B, hepatic glutathione was maintained at significantly higher levels than in controls, even after ischemia (P < 0.05). In group C, although hepatic GSH levels fell until reperfusion, after administration of NAC, hepatic GSH reached the level of the preischemia treatment group. In both treatment groups, GSH 1 hr after reperfusion was significantly higher than in the controls (P < 0.01): regeneration of glutathione was seen in all 6 animals in group C, compared with 2/6 in group B and none in the control group. ATP recovery, bile output, and survival were all better in the treatment groups than in the control group. Pretreatment with NAC helps maintain hepatic glutathione during warm ischemia; given after ischemia, NAC is effective in replenishing depleted glutathione stores. Adjunctive use of NAC was associated with improved glutathione homeostasis, improved bile output and ATP regeneration, and increased survival.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7839430     DOI: 10.1097/00007890-199501150-00002

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

1.  N-acetylcysteine induces shedding of selectins from liver and intestine during orthotopic liver transplantation.

Authors:  F J Taut; H Schmidt; C M Zapletal; J C Thies; C Grube; J Motsch; E Klar; E Martin
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

Review 2.  Experimental and clinical evidence for modification of hepatic ischaemia-reperfusion injury by N-acetylcysteine during major liver surgery.

Authors:  Santhalingam Jegatheeswaran; Ajith K Siriwardena
Journal:  HPB (Oxford)       Date:  2011-02       Impact factor: 3.647

3.  N-acetylcysteine administration does not improve patient outcome after liver resection.

Authors:  Stuart M Robinson; Rehan Saif; Gourab Sen; Jeremy J French; Bryon C Jaques; Richard M Charnley; Derek M Manas; Steven A White
Journal:  HPB (Oxford)       Date:  2013-01-07       Impact factor: 3.647

4.  Beneficial effects of N-acetyl cysteine on pancreas and kidney following experimental pancreatic ischemia-reperfusion in rats.

Authors:  Roberto Ferreira Meirelles Junior; Márcia Saldanha Kubrusly; Marta Bellodi-Privato; Nilza Aparecida Trindade Molan; Marcel Cerqueira Cesar Machado; Luis Augusto Carneiro D'Albuquerque
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

5.  Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury.

Authors:  Farin Amersi; Sally K Nelson; Xiu Da Shen; Hirohisa Kato; Judy Melinek; Jerzy W Kupiec-Weglinski; Lawrence D Horwitz; Ronald W Busuttil; Marcus A Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

6.  Glutathione ethyl ester supplementation during pancreatic islet isolation improves viability and transplant outcomes in a murine marginal islet mass model.

Authors:  Alexandre S Raposo do Amaral; Rena L Pawlick; Erika Rodrigues; Flavia Costal; Andrew Pepper; Flávio H Ferreira Galvão; Maria Lucia Correa-Giannella; A M James Shapiro
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

Review 7.  Mitochondrial Dysfunction and Autophagy in Hepatic Ischemia/Reperfusion Injury.

Authors:  Kristina L Go; Sooyeon Lee; Ivan Zendejas; Kevin E Behrns; Jae-Sung Kim
Journal:  Biomed Res Int       Date:  2015-12-06       Impact factor: 3.411

Review 8.  A systematic review of neuroprotective strategies after cardiac arrest: from bench to bedside (Part I - Protection via specific pathways).

Authors:  Dustin B Mangus; Lei Huang; Patricia M Applegate; Jason W Gatling; John Zhang; Richard L Applegate
Journal:  Med Gas Res       Date:  2014-05-01

9.  Combined use of N-acetylcysteine and Liberase improves the viability and metabolic function of human hepatocytes isolated from human liver.

Authors:  David C Bartlett; James Hodson; Ricky H Bhogal; Janine Youster; Phil N Newsome
Journal:  Cytotherapy       Date:  2014-03-15       Impact factor: 5.414

Review 10.  Recent insights into mitochondrial targeting strategies in liver transplantation.

Authors:  Rui Miguel Martins; João Soeiro Teodoro; Emanuel Furtado; Anabela Pinto Rolo; Carlos Marques Palmeira; José Guilherme Tralhão
Journal:  Int J Med Sci       Date:  2018-01-08       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.